We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
In Reference to COVID‐19 and the Otolaryngologist: Preliminary Evidence‐based Review.
- Authors
Baba, Yuh; Takada, Satoshi; Kato, Yasumasa
- Abstract
Dear Editor: We read with interest the review "COVID-19 and the Otolaryngologist: Preliminary Evidence-Based Review" by Vukkadala et al.1 In December 2019, the outbreak of coronavirus disease 2019 (COVID-19) infection, which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, was reported in Wuhan, China.2 During the COVID-19 pandemic, while the treatment for patients with non-urgent diseases is recommended to be postponed, diagnosis and treatment for the head and neck cancers (HNCs) must be continued as the same as before the pandemic, because the progress of HNCs is rapid and delay to the diagnosis and treatment can cause tumor progression and may negatively impact survival outcomes. However, during the COVID-19 pandemic, the examination is a high-risk procedure for HN surgical oncologists and otolaryngologists because of the high nasal viral loads in COVID-19 patients. Ideal biomarkers have high sensitivity and specificity, reversibility following proper treatment, and detectability before patients develop obvious clinical complaints of HNCs.
- Subjects
COVID-19; COVID-19 pandemic; CANCER diagnosis
- Publication
Laryngoscope, 2021, Vol 131, Issue 5, pE1460
- ISSN
0023-852X
- Publication type
Article
- DOI
10.1002/lary.29412